SUMMARY One hundred and fifty-two biopsies from serologically HBsAg positive and negative patients with liver disease were studied in immunofluorescence for the presence of the surface (HBs) and the core (HBc) (Hadziyannis, 1973; Gudat et al., 1975) 
cirrhotic patients. HB, without C fixation was observed in only three patients in the incubation phase of infectious hepatitis. IgG deposits were often found in HBc containing, C fixing nuclei. No C binding or IgG deposits were observed in acute self-limited type B hepatitis, in serologically positive patients with normal liver or minimal histological lesions, with and without HB% cytoplasmic fluorescence in their biopsy, or in serologically negative individuals.
The serological detection of hepatitis B core antibody (Hoofnagle et al., 1973) and the intrahepatic localisation of hepatitis B core antigen (HBc) by immunofluorescence (Hadziyannis, 1973; Gudat et al., 1975) The details of preparation and specificities of the antisera have already been described (Rizzetto et al., 1976 (Table 2) were left in cold phosphate buffered 3% glutaraldehyde for two hours, post-fixed in 1 % osmium tetroxide, and embedded in Araldite (Durcupan ACM Fluka). Staining was carried out with uranyl acetate (Watson, 1958) during alcoholic dehydration and lead citrate (Reynolds, 1963) was then applied to the section.
Results

IMMUNOFLUORESCENCE RESULTS
IFL results are summarised in Tables 1 and 2. No staining of the liver biopsy was observed in the 80 HB5Ag negative patients.
In Table 1 Reactions with all antisera were negative in 11 patients in the chronic liver disease group (Table 1) . In all HB0 positive biopsies, except three from patients incubating acute hepatitis, a strong nuclear and sometimes cytoplasmic fluorescence was observed after incubation with fresh human serum and subsequent staining with FITC antisera against human C3, C4, Clq (Fig. 1) ; this reaction was abolished after heating the serum at 560 for 30 minutes or after adding EDTA to the diluting buffer.
No C deposits were ever detected after direct staining with antisera to C components.
No C binding was observed in any of the biopsies from the 80 HBsAg negative patients or in those from serologically HBsAg positive patients which were negative in IFL or positive only for the cytoplasmic HBs determinant.
After previous incubation with fresh human serum and double staining with FITC anti HBR and RITC anti-human C3 conjugates, HB0 positive nuclei were often shown to fix complement; usually, however, C fixing cells outnumbered HBc reacting ones in advanced cirrhotic disease, while more HB0 positive than C binding hepatocytes were observed in early active hepatitis (Fig. 2a, b) .
In sections from HB0 positive biopsies reacting with HBs antiserum, double stained with RITC anti HBs and FITC anti C3 sera, many C fixing cells also showed large amounts of HB8 in their cytoplasm (Fig. 3a, b) . were repeatedly biopsied; an increase in C fixing and IgG nuclear deposits was noticed in later biopsies when compared with the first ones. In the post mortem specimen from patient no. 12 only a few nuclei were visualised with anti HBe serum, while IgG deposits and C binding activity were greatly increased compared with the first biopsy taken nine months earlier.
ELECTRON MICROSCOPE RESULTS
In the electron microscope (EM) the nuclei of the liver biopsy from patient no. 3 (Table 2 ) and of the necropsy specimen from patient no. 12 were filled with numerous particles about 200 A in diameter. These particles appeared as isolated or aggregated in clusters of a few units scattered in a rarefied karyoplasm (Fig. 4a) ; many of them displayed a central clear area, while some others appeared more homogeneously dense. At higher magnification the particles appeared to be composed of globular subunits about 30 A in diameter (Fig. 4b) .
Only a few isolated groups of such particles were detected in the nuclei from patient no. 13 (Table 2) ; the overall appearance of the karyoplasm was denser than in the previous patients.
Discussion
Several serological reactions associated with the hepatitis B virus have been described recently.
The system related to the Dane particle core (Almeida et al., 1971 ) has proved to be a marker of infectivity and chronic active disease; HB, antibodies appear to be a sensitive indicator of persistent Inner square. At higher magnification some virus-like particles show a clear area, others (large arrow) appear dense. In some particles globular subunits are present (thin arrow). x 164 000. viral replication (Hoofnagle et al., 1973) and HBR has been localised by IFL in the liver nuclei of patients with chronic active hepatitis (CAH) (Brzosko et al., 1973; Hadziyannis and Gerber, 1974; Gudat et al., 1975) . This determinant was not seen in the liver of healthy chronic carriers (Hadziyannis et al.,, 1973; Rizzetto et al., 1976) and was rarely observed in acute, self-limited hepatitis (Gudat et al., 1975) ; in this study, HBc was found by direct IFL in a high number of patients with chronic liver disease (Table 1) , and in three subjects from whom biopsies were taken while incubating acute hepatitis; it was sometimes associated with variable amounts of cytoplasmic HBs IFL.
In all HBR positive biopsies, except three, a strong nuclear and, less frequently, weaker cytoplasmic complement binding activity was observed, sometimes associated with nuclear deposits of IgG;
IgG, when present, was always located only in core positive nuclei, as shown by double staining with FITC anti HB0 and RITC anti IgG. With the same technique, it was shown that HBs, when present in HB0 positive biopsies, was often expressed in C fixing cells (Fig. la, b) .
None of 80 serologically HBsAg negative patients nor any biopsy reacting only with HB. antiserum, ever bound complement in vitro. The inverse relationship often observed between in vitro C fixation and direct core IFL (Table 2) , might be explained by a variable masking by immunoglobulins of HB0 determinants that are no longer available to the specific antiserum. There is, therefore, indirect evidence suggesting that core, complement fixing, immune complexes are formed in the liver of patients with chronic HBsAg positive hepatitis, and are somehow linked to the activity and progression of the disease; though the C system cannot enter the intact living cell, as shown by the absence of in vivo C3 binding, it is avidly fixed on the complexes exposed on the slide.
Whether IgG molecules enter an intact or damaged hepatocyte or are taken up as an immune complex with HBR, and how they get across the plasma membrane to the nucleus, is obscure; it has been repeatedly shown that the antinuclear antibodies found in systemic lupus erythematosus cannot penetrate an intact cell (Dubois, 1974) and, to our knowledge, there is no evidence of intranuclear complexes in parenchymal cells in human pathology.
At the ultrastructural level, spherical intranuclear virus-like particles were easily seen in large numbers in two patients with CAH (Fig. 4 a, b) and strong HBR IFL and C binding (nos. 3 and 12,  Table 2) ; only a few particles emerging from an electron dense amorphous material could be detected in a patient with cirrhosis (no. 13 Table 2 ); a similar aggregation of core particles was observed by Huang et al. (1974) and by Deutsch and Spence (1972) and interpreted by the latter author as immune aggregate formations.
Immunocomplexes involving the HB virus have been demonstrated by Nowoslawski et al. (1972) in the liver and in extrahepatic lesions in a significant percentage of subacute and chronic liver diseases and more recently IgG and C3 deposits were seen in HBR positive biopsies by Hadziyannis and Gerber (1974) , by Arnold et aL (1975) and by Sarno et at. (1975) , the latter authors suggesting that IgG staining was due to an antibody against HBR.
In this study, C fixation was observed in biopsies of untreated and steroid or azathioprine treated patients; in the clinical picture there was nothing specific to this group. A past history of acute hepatitis was recorded in six patients; the majority presented with signs of chronic disease, usually ascites.
The extension of C binding and HBc fluorescence appeared to correlate with the biochemical activity of the disease, not with a single morphological picture; the histological diagnosis varied from a chronic persistent hepatitis to an active cirrhosis.
Though a lesser number of positive cells were found in advanced disease, in these biopsies IgG positive and C fixing cells outnumbered as a rule those reacting with HBR antiserum; it could be argued that a sampling error is possible and might be anticipated as consistent because of the zonal distribution of immunofluorescence, yet in patients repeatedly subjected to biopsy, IgG and cytoplasmic C binding occurred for the first time in the second biopsy, whereas only widespread HBR and scattered nuclear C fixation were observed in the first one (nos. 3 and 12, Table 2 ).
The different IFL appearances in early or advanced disease might be the result of the progressive, persistent stimulation of the immune system with final complete masking of HBc reactivity by antibody excess in cirrhotic patients; however, whether and how this leads to chronic inflammation and to nodular transformation is at present unknown.
The hypothesis has been put forward that variations in the individual immune response determine the final outcome of exposure to HB virus (Dudley et a!., 1972; Gudat et al., 1975) . A normoergic reaction leads to sudden and massive destruction of infected hepatocytes and to acute hepatitis, a hypoergic one allows the individual to remove some but not all infected cells thus starting a vicious circle leading to chronic hepatitis. In this study no proof was obtained of a decreased immune response in chronic HBsAg positive liver disease: an abnor-mal, yet active response to the virus was always suggested by the IFL appearances and it is doubtful whether HBc is cytotoxic unless an immune reaction against it is mounted, as shown by its presence in the anergic incubation phase of acute hepatitis when no histological damage was yet apparent, and by the absence of aggressive lesions in immunosuppressed individuals harbouring large amounts of HB0 in their liver (Gudat et al., 1975) .
These conclusions give rise to considerable therapeutic implications. HBsAg chronic liver disease is currently treated with immunosuppressive drugs; though symptomatic relief is promptly achieved, it is not known whether they help to clear the virus, or, instead, assist its asymptomatic spread and replication by their immune-depressive action: evidence supporting this hypothesis has recently been presented by Galbraith et al. (1975) 
